Clinical Trial Update: Study Evaluating Rapid Infusion Rituximab in Patients With Autoimmune Diseases [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating rapid infusion rituximab in autoimmune diseases (Multiple Sclerosis) has completed with results posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Rituximab (rituximab)

Snippet

Sponsor: Wake Forest University Health Sciences | Conditions: Multiple Sclerosis | Phase 4 | Status: COMPLETED | Results posted: 2017-09-20